Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal bone remodelling and hormone replacement.

N H Bjarnason1, C Hassager, C Christiansen

  • 1Center for Clinical and Basic Research, Ballerup Byvej 222, 2750 Ballerup, Denmark.

Climacteric : the Journal of the International Menopause Society
|March 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.

Clinical chemistry·1995
Same author

Body composition and serum lipids in female runners: influence of exercise level and menstrual bleeding pattern.

European journal of clinical investigation·1995
Same author

Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest.

Bone·1995
Same author

Measurement of bone mineral density.

Calcified tissue international·1995
Same author

Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·1995
Same author

[The osteoporosis profile].

Ugeskrift for laeger·1995
Same journal

The International Menopause Society celebrates another milestone.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Impact of social determinants of health on perimenopause symptom burden: insights from the Flo app.

Climacteric : the journal of the International Menopause Society·2026
Same journal

From tissue to outcome - how perioperative vaginal estrogen transforms prolapse surgery results: a systematic review and meta-analysis of clinical evidence and outcomes.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Mapping menopause education for healthcare professionals: a scoping review.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Portuguese osteopaths' perceptions on the management of musculoskeletal conditions in menopausal women.

Climacteric : the journal of the International Menopause Society·2026
Same journal

Perimenopausal migraine: a narrative review.

Climacteric : the journal of the International Menopause Society·2026
See all related articles

Biochemical markers of bone turnover help assess osteoporosis, predicting bone loss and fracture risk. New serum markers offer reliable monitoring for treatment response and identifying patients needing intervention.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Endocrinology

Background:

  • Osteoporosis is a prevalent disease characterized by bone loss.
  • Accurate assessment of bone remodeling is crucial for evaluating bone loss, fracture risk, and treatment efficacy.
  • Bone turnover markers are essential tools in managing osteoporosis.

Purpose of the Study:

  • To highlight the importance of biochemical markers in assessing bone remodeling.
  • To demonstrate the predictive value of bone turnover markers for bone loss and fracture risk.
  • To discuss the role of these markers in monitoring treatment response.

Main Methods:

  • Review of existing literature on bone turnover markers and osteoporosis.
  • Analysis of the relationship between bone turnover, bone mass, and fracture risk.

Related Experiment Videos

  • Evaluation of the utility of biochemical markers in clinical practice.

    • Main Results:

    • High bone turnover, indicated by elevated biochemical markers, predicts accelerated bone loss and increased fracture risk.
    • Bone mass and bone turnover markers provide additive predictive information.
    • Hormone replacement therapy reduces bone turnover, preserves bone mass, and lowers fracture risk.
    • New serum markers show reduced day-to-day variation compared to urinary markers.

    Conclusions:

    • Biochemical markers of bone turnover are vital for evaluating osteoporosis.
    • Combining bone mass and bone turnover marker measurements can identify patients most in need of treatment and predict treatment response.
    • Serum markers offer a reliable method for monitoring osteoporosis management.